87 results
Page 2 of 5
8-K
EX-10.1
8lb3r5a66mqg p5ipm
5 Nov 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
pyk22jz2ohx5unu
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-10.1
lyx neo4mg5dx35k5uok
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
hfcjiukn9d rlk
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.1
63k72aszsn2c3c23m bi
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K/A
EX-99.2
48kuaka
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K
EX-99.1
brz7p
29 Sep 20
Theralink® Technologies Appoints Thomas Chilcott as Chief Financial Officer
4:05pm
8-K
EX-10.1
751gghxvooipt
22 Sep 20
Entry into a Material Definitive Agreement
12:00am
DEFM14C
g3sr2aloii6etqf09vj7
31 Aug 20
Information related to merger
7:00am
8-K/A
EX-99.1
u7bzaxhg9hdtx i1vt
19 Aug 20
Report of Independent Registered Public Accounting Firm
5:06pm
PREM14C
qjv629og5ujh5aj
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
gz9d75 1zo
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm